Short answer: both NMN and NR are NAD+ precursors used in cellular-health and cellular-energy formulations. They differ in molecular route, stability and handling, cost and format fit. NMN is widely requested by brands; NR is an established alternative precursor. There is also a liposomal NAD route for delivery-focused concepts. Choose based on route preference, stability, finished format and documentation — not on health-outcome claims.
NMN vs NR at a glance
| Property | NMN (Nicotinamide Mononucleotide) | NR (Nicotinamide Riboside) |
|---|---|---|
| Role | NAD+ precursor | NAD+ precursor |
| Market demand (US brands) | Very high, headline ingredient | Established, steady |
| Stability & handling | Manage moisture/heat; test in format | Manage moisture/heat; test in format |
| Best-fit finished formats | Capsules, sticks, powders, liposomal | Capsules, sticks, powders |
| Delivery options | Standard & liposomal (NADvitalize™) | Standard |
| Documentation | COA, assay, spec, stability | COA, assay, spec, stability |
| Claim posture | Structure/function only | Structure/function only |
Comparison of ingredient forms, handling and formats only. No anti-aging, longevity or disease claims are made or implied.
Choose NMN if…
You want the headline NAD+ precursor US brands are asking for, or you need liposomal and multi-format options for a differentiated concept.
Choose NR if…
You prefer an established alternative precursor route or already formulate around NR and want a reliable supply with full documentation.
Identity and Standardisation: What to Specify on a COA for NAD-Precursor Ingredients
NMN and NR are different molecules with different CAS registry numbers, molecular formulas and molecular weights — and neither of them is NAD itself. A specification that names the exact substance, its assay basis and its degradation limit is comparable across suppliers; a headline purity percentage alone is not.
| Substance | CAS No. | Molecular formula | MW (g/mol) | Specification note |
|---|---|---|---|---|
| β-Nicotinamide mononucleotide (NMN) | 1094-61-7 | C₁₁H₁₅N₂O₈P | 334.22 | Assayed as the free form; state the assay method alongside the percentage. |
| Nicotinamide riboside chloride (NR-Cl) | 23111-00-4 | C₁₁H₁₅ClN₂O₅ | 290.70 | Supplied as the chloride salt; ≈87.8% NR-cation equivalents by mass. |
| β-Nicotinamide adenine dinucleotide (NAD) | 53-84-9 | C₂₁H₂₇N₇O₁₄P₂ | 663.4 | The target coenzyme — a distinct molecule from both precursors; do not accept it as an assay substitute for either. |
| Nicotinamide | 98-92-0 | C₆H₆N₂O | 122.12 | Common degradation marker for both precursors; a complete specification states a limit for it. |
Salt basis vs cation basis. NR is supplied as nicotinamide riboside chloride (CAS 23111-00-4, MW 290.70). The NR cation itself accounts for 255.25 of that mass (290.70 − 35.45 for chloride), so the conversion factor is 255.25 ÷ 290.70 = 0.878. A lot assayed at “98%” on a salt basis therefore contains about 0.860 g of NR-cation equivalents per gram (0.98 × 0.878), i.e. ≈86.1%. Two quotes stating “98% NR” are not comparable unless both state whether the basis is the chloride salt or the cation.
A COA for one precursor cannot substantiate the other. NMN (CAS 1094-61-7, C₁₁H₁₅N₂O₈P, MW 334.22) and NR chloride (CAS 23111-00-4) are different substances, and NAD (CAS 53-84-9, MW 663.4) is different again. A quotation line that says only “NAD precursor” should name which molecule is being supplied and the basis on which it is assayed.
The degradation limit is part of identity. Nicotinamide (CAS 98-92-0) is a known degradation product relevant to both NMN and NR. A specification that carries a stated nicotinamide limit, the assay method, and the storage condition it applies under is more complete than one that carries a higher headline percentage without them. See how to compare ingredient quotes and how to verify a supplier COA for the full checklist.
Documentation & how to verify
For either precursor, request a Certificate of Analysis (COA), assay method, specification sheet and stability data. All Nutrition BioTech ingredients are produced within an ISO 22000 and GMP-certified quality system — see our certifications.
Frequently asked questions
What is the difference between NMN and NR?
Both are NAD+ precursors used in cellular-health formulations; they differ in molecular route, market demand, cost and format options. We describe them in formulation and documentation terms and do not make health-outcome claims.
Do you offer a liposomal NAD option?
Yes — our NAD platform includes standard NMN, NAD+, NADH and a liposomal NAD route (NADvitalize™) for delivery-focused concepts.
What documentation do you provide?
COA, assay method, specification sheet and stability data on request.
Can I request samples of NMN and NR to compare?
Yes — request samples, minimum order quantity and lead time via our contact page.
How do I convert an NR chloride assay to NR-cation equivalents?
Multiply the salt-basis assay by 0.878 (255.25 ÷ 290.70). For example, a lot assayed at 98% nicotinamide riboside chloride contains about 0.860 g of NR-cation equivalents per gram, or ≈86.1%. Always confirm which basis the COA states before comparing quotes.
Is a COA for NMN interchangeable with a COA for NR?
No. NMN (CAS 1094-61-7) and nicotinamide riboside chloride (CAS 23111-00-4) are different molecules with different formulas and molecular weights, so each lot must be identity-tested and assayed as the substance actually supplied. NAD itself (CAS 53-84-9) is a third, distinct molecule.
Why should a nicotinamide limit appear on an NMN or NR specification?
Nicotinamide (CAS 98-92-0) is a common degradation product of both precursors, so its level is a practical indicator of lot handling and stability. Ask for the stated limit, the assay method, and the storage condition it was measured under as part of standard COA review.
Explore the NAD ingredient platform → | Request a sample, COA or spec →